Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation

BJU Int. 2021 Feb;127(2):175-178. doi: 10.1111/bju.15277. Epub 2020 Nov 13.

Authors

Ivo G Schoots^{1

2}, Anwar R Padhani³

Affiliations

¹ Department of Radiology and Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
² Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
³ Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, UK.

No abstract available

Publication types

Review

MeSH terms

Decision Making*
Humans
Image-Guided Biopsy / methods*
Magnetic Resonance Imaging / methods*
Male
Prostate / pathology*
Prostate-Specific Antigen / metabolism*
Prostatic Neoplasms / diagnosis*
Prostatic Neoplasms / metabolism

Substances

Prostate-Specific Antigen